×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Adynxx, Inc. (New). (ALQA) NASDAQ

- - (-)

Market Cap: -

As of 12/05/23 04:00 PM EST. Market closed.

(ALQA)

Adynxx, Inc. (New). (ALQA)
NASDAQ

-
- (-)

Market Cap: -

As of 12/05/23 04:00 PM EST. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Health Technology
Industry
Pharmaceuticals: Major
URL
Address
.
Sector
Health Technology
Industry
Pharmaceuticals: Major
Address
.
PRICE CHART FOR ADYNXX, INC. (NEW)
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0.45
Days Range
- - -
52 week range
$7.36 - $31.44
Volume
0
Avg. Volume (30 days)
18,760
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$0.45
Days Range
- - -
52 week range
$7.36 - $31.44
Volume
0
Avg. Volume (30 days)
18,760
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR ADYNXX, INC. (NEW)
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ADYNXX, INC. (NEW)
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
BARTON BRADFORDChief Operating OfficerSep 21, 2017 Option Exercise$0.4267,53628,365558,822Sep 25, 2017, 04:41 PM
POSNER BRIAN MChief Financial OfficerSep 21, 2017 Option Exercise$0.4270,83329,750476,421Sep 25, 2017, 04:20 PM
Pionati PellegrinoSee RemarksSep 21, 2017 Option Exercise$0.4269,97829,391506,601Sep 25, 2017, 04:11 PM
Pionati PellegrinoSee RemarksJun 15, 2017 Option Exercise$0.3710,0323,712270,864Jun 21, 2017, 05:30 PM
WAGNER MARK TDirectorMar 21, 2017 Option Exercise$0.6775,87650,837323,802Apr 04, 2017, 09:05 AM
WAGNER MARK TDirectorApr 03, 2017 Buy$0.4062,50025,00070,500Apr 04, 2017, 09:05 AM
BARTON BRADFORDChief Operating OfficerApr 03, 2017 Buy$0.4075,00030,000320,643Apr 04, 2017, 09:04 AM
LEONE JOSEPH MDirectorApr 03, 2017 Buy$0.4025,00010,00043,823Apr 04, 2017, 09:02 AM
Pionati PellegrinoSee RemarksApr 03, 2017 Buy$0.4050,00020,000280,896Apr 04, 2017, 09:02 AM
Johnson David IanPresident and CEOApr 03, 2017 Buy$0.40250,000100,0001,194,535Apr 04, 2017, 09:00 AM
ZELDIS JEROME BDirectorFeb 27, 2017 Buy$0.50400,000200,000686,750Mar 01, 2017, 06:04 AM
WAGNER MARK TDirectorMar 16, 2016 Option Exercise$2.6173,893192,861247,926May 20, 2016, 03:29 PM
Sklar JeffreyDirectorNov 06, 2015 Buy$2.951,5004,42524,357Nov 12, 2015, 08:41 AM
POSNER BRIAN MChief Financial OfficerNov 09, 2015 Buy$3.045,00015,200116,881Nov 10, 2015, 10:53 AM
BARTON BRADFORDChief Operating OfficerNov 06, 2015 Buy$2.975,00014,850120,985Nov 09, 2015, 03:08 PM
Johnson David IanPresident and CEONov 06, 2015 Buy$2.928,65025,258584,603Nov 09, 2015, 12:04 PM
LEONE JOSEPH MDirectorNov 06, 2015 Buy$2.783,5009,73018,823Nov 09, 2015, 12:00 PM
WAGNER MARK TDirectorNov 06, 2015 Buy$2.888,00023,0408,000Nov 09, 2015, 11:58 AM
ZELDIS JEROME BDirectorNov 06, 2015 Buy$2.9114,00040,740286,750Nov 09, 2015, 11:55 AM
Pionati PellegrinoChief Strategy & Marketing OffNov 06, 2015 Buy$2.9510,00029,500116,512Nov 09, 2015, 11:50 AM
POSNER BRIAN MChief Financial OfficerAug 10, 2015 Buy$5.022,50012,550111,881Aug 10, 2015, 11:47 AM
Johnson David IanPresident and CEOJul 01, 2015 Option Exercise$5.3519,191102,672575,953Jul 06, 2015, 04:15 PM
Pionati PellegrinoSee RemarksJun 15, 2015 Option Exercise$5.2513,48870,812106,512Jun 17, 2015, 04:06 PM
BARTON BRADFORDChief Operating OfficerJun 08, 2015 Buy$5.243,00015,735115,985Jun 10, 2015, 10:00 AM
Johnson David IanPresident and CEOMay 27, 2015 Buy$4.6510,00046,458595,144May 28, 2015, 02:02 PM
POSNER BRIAN MChief Financial OfficerMay 20, 2015 Buy$4.342,50010,850109,381May 20, 2015, 11:41 AM
CELGENE CORP /DE/10% OwnerMay 04, 2015 Buy$4.55659,3402,999,9973,046,100May 04, 2015, 04:19 PM
Johnson David IanPresident and CEOApr 01, 2015 Option Exercise$5.1920,590106,862585,144Apr 03, 2015, 04:28 PM
Johnson David IanPresident and CEOMar 06, 2015 Option Exercise$5.297,67340,590605,734Mar 10, 2015, 04:25 PM
POSNER BRIAN MChief Financial OfficerMar 06, 2015 Option Exercise$5.297594,015106,881Mar 10, 2015, 04:24 PM
BARTON BRADFORDChief Operating OfficerMar 06, 2015 Option Exercise$5.292,22511,770112,985Mar 10, 2015, 04:24 PM
Johnson David IanPresident and CEOJan 01, 2015 Option Exercise$5.3021,681114,909313,407Jan 05, 2015, 05:28 PM
Johnson David IanPresident and CEOOct 01, 2014 Option Exercise$4.8420,55299,472335,088Oct 02, 2014, 11:56 AM
POSNER BRIAN MChief Financial OfficerSep 15, 2014 Buy$4.942,0009,8807,640Sep 16, 2014, 12:33 PM
ZELDIS JEROME BDirectorSep 03, 2014 Option Exercise$4.2423,50099,640272,750Sep 04, 2014, 11:50 AM
Johnson David IanPresident and CEOJul 01, 2014 Option Exercise$5.7420,367116,907355,640Jul 14, 2014, 10:09 AM
ZELDIS JEROME BDirectorJun 06, 2014 Option Exercise$4.2423,50099,640249,250Jun 10, 2014, 02:18 PM
POSNER BRIAN MChief Financial OfficerMay 13, 2014 Buy$6.923,00020,7605,640May 13, 2014, 11:41 AM
CELGENE CORP /DE/10% OwnerApr 14, 2014 Buy$7.00714,2865,000,0022,386,760Apr 15, 2014, 04:01 PM
Johnson David IanPresident and CEOApr 01, 2014 Option Exercise$8.2520,186166,535376,007Apr 03, 2014, 07:56 PM
SAPIRSTEIN JAMESCEO, Therapeutics DivisionJan 09, 2014 Option Exercise$8.187,10458,11131,662Jan 17, 2014, 04:40 PM
Johnson David IanPresident and CEOJan 06, 2014 Option Exercise$6.9919,245134,523378,369Jan 08, 2014, 09:10 PM
SAPIRSTEIN JAMESCEO, Alliqua Biomedical, Inc.Nov 27, 2013 Option Exercise$4.4614,29963,77421,078Dec 23, 2013, 06:00 PM
LONDONER KENNETH LDirectorMay 21, 2013 Buy$0.0738,5002,6951,859,500May 23, 2013, 03:21 PM
LONDONER KENNETH LDirectorMay 20, 2013 Buy$0.07181,00012,3641,821,000May 23, 2013, 03:21 PM
Kalen Capital Corp10% OwnerMar 28, 2012 Sale$0.0424,057,980962,3190Mar 29, 2012, 02:07 PM
Sklar JeffreyDirectorJun 02, 2011 Buy$0.1130,0003,300280,000Jun 06, 2011, 04:18 PM
1420525 ALBERTA LTD.10% OwnerOct 21, 2009 Option Exercise$0.151,032,706154,90631,057,980Apr 04, 2011, 05:49 PM
1420525 ALBERTA LTD.10% OwnerMar 30, 2011 Option Exercise$0.057,000,000350,00024,057,980Apr 04, 2011, 05:49 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
BARTON BRADFORDChief Operating Officer09/21/201728,365
POSNER BRIAN MChief Financial Officer09/21/201729,750
Pionati PellegrinoSee Remarks09/21/201729,391
Pionati PellegrinoSee Remarks06/15/20173,712
WAGNER MARK TDirector03/21/201750,837
WAGNER MARK TDirector04/03/201725,000
BARTON BRADFORDChief Operating Officer04/03/201730,000
LEONE JOSEPH MDirector04/03/201710,000
Pionati PellegrinoSee Remarks04/03/201720,000
Johnson David IanPresident and CEO04/03/2017100,000
ZELDIS JEROME BDirector02/27/2017200,000
WAGNER MARK TDirector03/16/2016192,861
Sklar JeffreyDirector11/06/20154,425
POSNER BRIAN MChief Financial Officer11/09/201515,200
BARTON BRADFORDChief Operating Officer11/06/201514,850
Johnson David IanPresident and CEO11/06/201525,258
LEONE JOSEPH MDirector11/06/20159,730
WAGNER MARK TDirector11/06/201523,040
ZELDIS JEROME BDirector11/06/201540,740
Pionati PellegrinoChief Strategy & Marketing Off11/06/201529,500
POSNER BRIAN MChief Financial Officer08/10/201512,550
Johnson David IanPresident and CEO07/01/2015102,672
Pionati PellegrinoSee Remarks06/15/201570,812
BARTON BRADFORDChief Operating Officer06/08/201515,735
Johnson David IanPresident and CEO05/27/201546,458
POSNER BRIAN MChief Financial Officer05/20/201510,850
CELGENE CORP /DE/10% Owner05/04/20152,999,997
Johnson David IanPresident and CEO04/01/2015106,862
Johnson David IanPresident and CEO03/06/201540,590
POSNER BRIAN MChief Financial Officer03/06/20154,015
BARTON BRADFORDChief Operating Officer03/06/201511,770
Johnson David IanPresident and CEO01/01/2015114,909
Johnson David IanPresident and CEO10/01/201499,472
POSNER BRIAN MChief Financial Officer09/15/20149,880
ZELDIS JEROME BDirector09/03/201499,640
Johnson David IanPresident and CEO07/01/2014116,907
ZELDIS JEROME BDirector06/06/201499,640
POSNER BRIAN MChief Financial Officer05/13/201420,760
CELGENE CORP /DE/10% Owner04/14/20145,000,002
Johnson David IanPresident and CEO04/01/2014166,535
SAPIRSTEIN JAMESCEO, Therapeutics Division01/09/201458,111
Johnson David IanPresident and CEO01/06/2014134,523
SAPIRSTEIN JAMESCEO, Alliqua Biomedical, Inc.11/27/201363,774
LONDONER KENNETH LDirector05/21/20132,695
LONDONER KENNETH LDirector05/20/201312,364
Kalen Capital Corp10% Owner03/28/2012962,319
Sklar JeffreyDirector06/02/20113,300
1420525 ALBERTA LTD.10% Owner10/21/2009154,906
1420525 ALBERTA LTD.10% Owner03/30/2011350,000
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR ADYNXX, INC. (NEW)
LOADING...